CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Perfuze has developed a novel aspiration catheter technology for stroke treatment that allows for the removal of blood clots in a single attempt. This device simplifies the procedure, enabling faster and more effective treatment for patients experiencing ischemic strokes.
Stroke is the third most common cause of death globally and is the leading cause of adult physical disability.
Globally, seventeen million people had a stroke in 20152.
Of these, 33% died and 33% were permanently disabled. A stroke occurs when a blood vessel in the brain is blocked by a clot, preventing blood flow, and causing brain damage.
Stroke is a devastating disease.Perfuze has developed aspiration catheter technology intended to ingest the clot in a single attempt.
No accessory devices or…
PERFUZE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
